Unicycive Therapeutics, Inc. (UNCY)
5.16
-0.14
(-2.64%)
USD |
NASDAQ |
Sep 04, 16:00
5.155
0.00 (0.00%)
Pre-Market: 20:00
Unicycive Therapeutics SG&A Expense (TTM) : 23.53M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.53M |
| March 31, 2026 | 21.40M |
| December 31, 2025 | 20.38M |
| September 30, 2025 | 19.38M |
| June 30, 2025 | 18.21M |
| March 31, 2025 | 15.53M |
| December 31, 2024 | 12.10M |
| September 30, 2024 | 10.21M |
| June 30, 2024 | 9.57M |
| March 31, 2024 | 9.092M |
| December 31, 2023 | 8.548M |
| September 30, 2023 | 7.953M |
| June 30, 2023 | 7.089M |
| March 31, 2023 | 6.81M |
| Date | Value |
|---|---|
| December 31, 2022 | 6.567M |
| September 30, 2022 | 6.473M |
| June 30, 2022 | 5.71M |
| March 31, 2022 | 4.22M |
| December 31, 2021 | 2.897M |
| September 30, 2021 | 1.841M |
| June 30, 2021 | 1.223M |
| March 31, 2021 | 1.092M |
| December 31, 2020 | 1.005M |
| September 30, 2020 | 0.995M |
| June 30, 2020 | 0.967M |
| March 31, 2020 | 0.812M |
| December 31, 2019 | 0.618M |
| September 30, 2019 | 0.293M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Theriva Biologics, Inc. | 6.919M |
| AbbVie, Inc. | 14.67B |
| Decoy Therapeutics, Inc. | 4.096M |
| Yarrow Bioscience, Inc. | 10.57M |